Tomohiro Hosoya

Tottori, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Correction: Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression.

Correction: Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression.

Journal: Scientific reports

Published: March 11, 2026

Efficacy and safety profiles of single versus multiple pipeline embolization devices for intracranial aneurysms: a systematic review and meta-analysis.

Efficacy and safety profiles of single versus multiple pipeline embolization devices for intracranial aneurysms: a systematic review and meta-analysis.

Journal: Neurosurgical review

Published: October 20, 2025

Drug-induced hypertension is associated with improved survival in glioblastoma patients treated with bevacizumab: evidence from a time-to-event meta-analysis and meta-regression.

Drug-induced hypertension is associated with improved survival in glioblastoma patients treated with bevacizumab: evidence from a time-to-event meta-analysis and meta-regression.

Journal: Neurosurgical review

Published: August 23, 2025

Microvessel density as a prognostic and predictive biomarker in newly diagnosed glioblastoma: correlations with radiological features and bevacizumab efficacy.

Microvessel density as a prognostic and predictive biomarker in newly diagnosed glioblastoma: correlations with radiological features and bevacizumab efficacy.

Journal: Journal of neuro-oncology

Published: July 20, 2025

Prognostic value of hypertension timing for survival in glioblastoma patients receiving bevacizumab: a retrospective single centre analysis.

Prognostic value of hypertension timing for survival in glioblastoma patients receiving bevacizumab: a retrospective single centre analysis.

Journal: Journal of neuro-oncology

Published: June 19, 2025

Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression.

Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression.

Journal: Scientific reports

Published: May 20, 2025

Low-Grade Primary Intramedullary Spinal Cord Astroblastoma: A Case Report and Literature Review.

Low-Grade Primary Intramedullary Spinal Cord Astroblastoma: A Case Report and Literature Review.

Journal: Neuropathology : official journal of the Japanese Society of Neuropathology

Published: April 27, 2025

Which surgical technique has a superior clinical outcome in microvascular decompression? a systematic review and meta-analysis study of transposition versus interposition for trigeminal neuralgia and hemifacial spasm.

Which surgical technique has a superior clinical outcome in microvascular decompression? a systematic review and meta-analysis study of transposition versus interposition for trigeminal neuralgia and hemifacial spasm.

Journal: Neurosurgical review

Published: February 03, 2025

Early progressive disease within 2 years in isocitrate dehydrogenase (IDH)-mutant astrocytoma may indicate radiation necrosis.

Early progressive disease within 2 years in isocitrate dehydrogenase (IDH)-mutant astrocytoma may indicate radiation necrosis.

Journal: Japanese journal of clinical oncology

Published: July 09, 2024

Clinical Outcome of Pipeline Embolization Device with and without Coils to Treat Intracranial Aneurysm: A Systematic Review and Meta-Analysis.

Clinical Outcome of Pipeline Embolization Device with and without Coils to Treat Intracranial Aneurysm: A Systematic Review and Meta-Analysis.

Journal: AJNR. American journal of neuroradiology

Published: June 03, 2024

Mechanism and significance of diffusion restriction followed by calcification in high-grade glioma treated with bevacizumab.

Mechanism and significance of diffusion restriction followed by calcification in high-grade glioma treated with bevacizumab.

Journal: Scientific reports

Published: May 13, 2024

The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment.

The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment.

Journal: Journal of neuro-oncology

Published: November 26, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026